Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SOPHiA GENETICS (SOPH) Net Cash Flow (2020 - 2025)

Historic Net Cash Flow for SOPHiA GENETICS (SOPH) over the last 6 years, with Q3 2025 value amounting to -$13.3 million.

  • SOPHiA GENETICS's Net Cash Flow fell 2154.48% to -$13.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.8 million, marking a year-over-year increase of 5924.91%. This contributed to the annual value of -$40.6 million for FY2024, which is 1353.37% up from last year.
  • Per SOPHiA GENETICS's latest filing, its Net Cash Flow stood at -$13.3 million for Q3 2025, which was down 2154.48% from $23.9 million recorded in Q2 2025.
  • SOPHiA GENETICS's Net Cash Flow's 5-year high stood at $168.8 million during Q3 2021, with a 5-year trough of -$20.8 million in Q3 2022.
  • For the 5-year period, SOPHiA GENETICS's Net Cash Flow averaged around $135052.6, with its median value being -$12.7 million (2025).
  • Its Net Cash Flow has fluctuated over the past 5 years, first plummeted by 270749.57% in 2023, then skyrocketed by 159680.17% in 2025.
  • Over the past 5 years, SOPHiA GENETICS's Net Cash Flow (Quarter) stood at -$17.2 million in 2021, then surged by 103.42% to $587000.0 in 2022, then plummeted by 2707.5% to -$15.3 million in 2023, then grew by 4.32% to -$14.6 million in 2024, then rose by 9.2% to -$13.3 million in 2025.
  • Its Net Cash Flow was -$13.3 million in Q3 2025, compared to $23.9 million in Q2 2025 and -$12.7 million in Q1 2025.